Skip to main content


Transparency and Ethics

Information about Janssen’s transparency data


HCP Report

1 May 2017 - 31 Oct 2017    PDF

1 Nov 2016 - 30 Apr 2017    PDF

1 May 2016 - 31 Oct 2016    PDF

1 Oct 2015 - 30 Apr 2016    PDF


At Janssen Australia we believe that partnering with the medical community is essential to advancing clinical care and improving patients’ lives. As a member of Medicines Australia, the industry association representing discovery driven pharmaceutical companies, we are committed to being open and transparent when we provide a Reportable Payment or Transfer of Value to a healthcare professional.

Reportable Payments or Transfers of Value are:

  • Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an advisory board or as a consultant.
  • Airfares, accommodation and/or conference registration fees to attend medical education as part of those services.

Janssen prepares a report for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and the Privacy Act 1988 (Cth) (“Act”). The report identifies healthcare professionals by name where their express consent has been previously provided. Where express consent has not been provided the information is reported in aggregate.

Healthcare professionals have a general right under the Act, subject to certain exceptions, to access or correct personal information, including the report. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Act.

Each six-monthly report will be available for at least three years from publication date, 31 August and 28 February.

For further information about the details in the report, please go to